• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION UV ABSORBING IOL; INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LLC - HUNTINGTON ACRYSOF IQ VIVITY EXTENDED VISION UV ABSORBING IOL; INTRAOCULAR LENS Back to Search Results
Model Number DAT015
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Blurred Vision (2137); Visual Impairment (2138)
Date of Event 12/30/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The explanted lens was returned in the replacement lens case.Solution was dried on the lens.The anterior optic surface was scratched.Product history records were reviewed and the documentation indicated the product met release criteria.Information indicated the use of a qualified cartridge and handpiece.A non-qualified viscoelastic was indicated.The root cause was determined to be most likely unrelated to the lens.The initial report was for blurred visual acuity optics, residual cylinder, and s/p lasik likely source of blur.Each lens is subjected to a 100% assessment of the power and optical resolution during the manufacturing process in order to determine acceptability per the lens model and diopter.The information provided by the facility indicate that in the surgeon's opinion, the lens did not cause or contribute to the event.The cause was written as optics, residual cylinder and s/p lasik.Information was provided that the company lens was removed and replaced with a non-company lens.The manufacturer internal reference number is: (b)(4).
 
Event or Problem Description
A non health care professional reported following the intraocular lens implantation the patient had experienced blurry vision, residual cylinder.The lens was explanted in a secondary surgery and was replaced with a different lens.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACRYSOF IQ VIVITY EXTENDED VISION UV ABSORBING IOL
Common Device Name
INTRAOCULAR LENS
Manufacturer (Section D)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LLC - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key13421391
Report Number1119421-2022-00153
Device Sequence Number17615556
Product Code POE
UDI-Device Identifier00380652424639
UDI-Public00380652424639
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
P930014
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Device Explanted Year2022
Reporter Type Manufacturer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 02/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/15/2025
Device Model NumberDAT015
Device Lot Number15099688
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/27/2022
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 01/11/2022
Initial Report FDA Received Date02/02/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/16/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
HEALON; MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE D; MONARCH III IOL DELIVERY SYSTEM, INJECTOR; ZA9003+20.0 SN (B)(4)
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
Patient SexFemale
-
-